How Rite Aid Performed in 2Q17

1 2 3 4 5
How Rite Aid Performed in 2Q17 PART 1 OF 5

Key Takeaways from Rite Aid’s 2Q17 Results

Snapshot of the series

Rite Aid (RAD) reported results for 2Q17 on Thursday, September 28, 2017. The results relate to the three-month period ending September 2, 2017. The Pennsylvaniabased pharmacy chain reported in-line earnings but missed on Wall Street revenue forecasts. It reported a loss of one cent per share on total sales of $7.7 billion. Read the next three parts of this series to know more about the company’s 2Q17 performance.

Key Takeaways from Rite Aid’s 2Q17 Results

Interested in CVS? Don't miss the next report.

Receive e-mail alerts for new research on CVS

Success! You are now receiving e-mail alerts for new research. A temporary password for your new Market Realist account has been sent to your e-mail address.

Success! has been added to your Ticker Alerts.

Success! has been added to your Ticker Alerts. Subscriptions can be managed in your user profile.

Rite Aid’s stock price plunged 11% after results. It closed at $2.03 on September 28, touching its four-year low. Read part five of the series to know about the company’s year-to-date stock market performance.

About Rite Aid

Rite Aid is America’s third largest pharmacy retail chain, following CVS Health (CVS) and Walgreens Boots Alliance (WBA). Recently, Walgreens acquired 1,932 Rite Aid stores along with its three distribution centers for $4,375 million. The deal is expected to close by the spring of 2018. All acquired Rite Aid stores will be converted into Walgreens stores in a phased manner. Rite Aid now operates close to 2,700 stores in the US.

Eight Wall Street analysts cover the company. Seven of them have given a “hold” recommendation on the stock, while one analyst has suggested a “buy.”

Investors looking for exposure in Rite Aid through ETFs can choose to invest in the First Trust Consumer Staples AlphaDEX Fund (FXG), which invests 1.2% of its portfolio in the company.


Please select a profession that best describes you: